ICP: the pressure exerted by the cranium onto brain tissue, CSF and intracranial circulating blood volume
Aetiology
Causes of increased ICP
- Mass effect e.g. tumour - distort surrounding brain
- Brain swelling due to e.g. ischaemia, acute liver failure
- Increase in central venous pressure e.g. venous sinus thrombosis
- Problems with CSF flow
- Obstruction ('obstructive hydrocephalus') - masses, Chiari syndrome
- Increased production - choroid plexus papilloma
- Decreased absorption ('communicating hydrocephalus') - SAH, meningitis, malignant meningeal disease
Pathophysiology
- ICP is constantly fluctuating but at rest 7-15 mmHg
- Can be negative in vertical position
- The Monroe-Kellie Doctrine is a compensatory mechanism for expanding masses
- Immediate: decrease in CSF volume by moving it out of FM, decrease in blood volume by squeezing sinuses
- Delayed: decrease in ECF
- CSF is secreted by the choroid plexus → ventricular system → subarachnoid space (Magendie and Luschka) → venous system (arachnoid granulations)
- Any obstruction in this flow will lead to hydrocephalus and increased ICP
- Cerebral perfusion pressure (CPP) = MAP - ICP
- Cerebral blood flow = CPP/cerebral vascular resistance
- Autoregulation of CBF over wide range of BP, CBF remains constant, exact mechanism is unknown
- Pressure autoregulation - arterioles dilate or constrict in response to changes in BP or ICP
- Metabolic autoregulation - arterioles dilate in response to chemicals e.g. CO2
- Other theories include myogenic theory (direct reaction of smooth muscle to stretch)
Clinical presentation of raised ICP
Early signs
- Decreased level of consciousness
- Pupillary dysfunction +/- papilloedema
Later signs
- Bradycardia → Cushing's triad
Normal pressure hydrocephalus
- Idiopathic disease of the elderly, possibly due to decreased brain elastance
Clinical presentation
- Hakim's triad: abnormal gait, urinary incontinence, dementia
Investigations
- LP, lumbar drain test, lumbar infusion studies
Management
- VP shunt, medium-low or low-pressure valve
Idiopathic intracranial hypertension
- Condition characterized by increased intracranial pressure (pressure around the brain) without a detectable cause
Aetiology
- Typically develops in younger, overweight female patients, many of whom have polycystic ovaries
- Probably results from reduced CSF resorption
Clinical presentation
- Double vision, visual blurring
- Papilloedema → 25% severe/permanent visual loss
Investigations
- No ventricular dilation → normal CT
- LP, CT/MR head, CTV, fundoscopy +/- opthalmology review
Management
- Carboanhydrase inhibitors - acetazolamide, topiramate
- Ventricular atrial/lumbar peritoneal shunt
- Monitor visual fields and CSF pressure
Management of other causes of rasied ICP
- Goals of therapy are to maintain CPP and prevent ischaemia and brain compression
Initial management
- Maintain head in midline to facilitate blood flow
- Loosen tube ties, collars etc.
- HoB 30-45 degrees elevation
- Avoid gagging, coughing etc.
- Decrease environmental stimuli
- Maintain fluid balance and electrolytes
Medical management
- Diuretics - hypertonic saline
Surgical management
- Other surgical treatment - remove mass lesions, CSF diversion